News | June 05, 2008

Age May Impact Patients' Ability to Repair Arteries

June 5, 2008 - Older patients may have less ability to repair of vessels and arteries after acute injury, similar to other effects of aging, according to the American Vascular Association (AVA) Resident Research Prize Paper, presented at the 62nd Annual Meeting of the Society for Vascular Surgery.

With an aging population, increasing focus is on treating conditions that develop in later life, such as atherosclerosis and its progression to ischemia. Many times ischemia is found in the lower extremities in older individuals. Older patients are thought to have less tolerance to acute ischemia than younger patients, often leading to poor outcomes resulting in increased risk of mortality and amputation.

Study author and Resident Research Prize recipient Tormod S. Westvik, M.D., a resident at the Yale University School of Medicine, New Haven, CN, described how researchers created a model mimicking severe leg ischemia, to examine the effects of age and whether it depresses the regeneration of blood vessels and arteries in severe acute limb ischemia.

Dr. Westvik explained in the lab 15 young adult (three months) and 20 aged (18 months) mice underwent right common iliac artery and vein ligation and transection. Data were collected on days 0, 7 and 14. After severe hindlimb ischemia, both groups of mice had a similar degree of decreased perfusion and all became ischemic. Older mice had a significantly impaired arteriogenesis and functional recovery after 14 days. Aged mice also had increased capillary density and endiothelial progenitor cell numbers compared to young mice, but diminished collateral supply to the ischemic limb.

"On a biological level, both groups of mice produced the components necessary to form new vessels. However, only the young animals succeeded in arranging these components into functioning vessels which improved blood flow to the injured leg," said Dr. Westvik. "These results suggest that strategies to stimulate arteriogenesis may complement those that increase angiogenesis, thus may result in improved relief of ischemia."

"Based on the results in our study, we propose that further investigations should be aimed at improving the ability of older animals (and subsequently patients) to arrange these available components into functioning vessels, thus improving the outcome after acute ischemia," said Dr. Westvik.

The AVA Resident Research Prize is intended to motivate physicians, early in their training, to pursue their interest in research and offer the opportunity to present their research at the Vascular Annual Meeting. The Resident Research Prize includes a $5,000 award and the opportunity to present the winner's work at the Vascular Annual Meeting and have it published in the Journal of Vascular Surgery.

For more information: www.VascularWeb.org


Related Content

News | Cardiovascular Clinical Studies

Nov. 18, 2024 — Silence Therapeutics presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran, a ...

Home November 18, 2024
Home
News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
Subscribe Now